
The drug is already being marketed in the EU, the US, and Australia.
Indian benchmark indices BSE Sensex, NSE Nifty 50 stare at a muted start amid mixed global cues. ITC, Glenmark Pharma,…
The ARNI market (sacubitril + valsartan) is estimated to be Rs. 514 Crore; with an annual growth of 37.2%.
Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as congestive heart failure, liver…
Earlier this year, Glenmark also launched Sitagliptin (Sitazit) and its FDCs, followed by Lobeglitazone (LOBG) and FDCs of Teneligliptin including…
Nicardipine Hydrochloride Capsules are indicated for to treat severe chest pain (angina) or high blood pressure (hypertension).
GNP to enhance its exiting brand franchise; focus on core therapies
According to the company, the drug will be marketed under the brand name LOBG and it contains Lobeglitazone (0.5 mg).
According to the company, RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal…
Health Canada granted approval to partner Bausch Health Companies Inc and Glenmark Specialty SA, a subsidiary of the company, for…
According to the company, RYALTRIS is the only fixed-dose combination therapy that provides relief for the symptoms of SAR, both…
According to reports, the regulatory scrutiny of the Indian drug makers has increased this year, as the USFDA reconvened physical…
In the last financial year, India’s pharma exports stood at around USD 24.62 billion with the US, the UK, South…
Meanwhile, the revenue from operations declined to Rs 2,777 crore in the June quarter as compared with Rs 2,965 crore…
Meanwhile, Glenmark’s current portfolio consists of 177 products authorised for distribution in the U.S. marketplace and 47 ANDA’s pending approval…
Reportedly, the Mumbai-based drug major is recalling the affected lot due to “water leakage” leading to deviation from current good…
The study demonstrated that patients who received NONS had significant reduction in viral load within 24 hours, which was sustained…
MINYM® Gel (Topical Minocycline 4% Gel) has been developed to address these growing concerns in the treatment of acne and…
Minocycline 4 per cent gel is a potent antibacterial gel that exerts a strong anti-inflammatory action. It also offers the…
Moreover, in India, patients have to bear the drug cost on their own and so the price of the drug…
Currently, Glenmark’s portfolio consists of 175 products authorized for distribution in the U.S. marketplace and 48 ANDAs pending approval with…
The acquisition by the company’s fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for…
Loading…
Something went wrong. Please refresh the page and/or try again.